ANAVEX LIFE SCIENCES CORP. Increase (Decrease) in Accounts Receivable
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Increase (Decrease) in Accounts Receivable of $53.14 thousand for the 9-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2019-08-07
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for the quarter ending 2019-06-30 was $17.15K, a 1412.70% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for the quarter ending 2019-03-31 was $45.79K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for the quarter ending 2018-12-31 was -$9.80K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for the quarter ending 2018-09-30 was $34.03K, a 2121.02% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for fiscal 2018 was $30.42K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for fiscal 2017 was -$54.44K, a 2271.32% decline from fiscal 2016.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for fiscal 2016 was $2.51K, a 96.74% decline from fiscal 2015.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accounts receivable for fiscal 2015 was $76.84K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2019-06-30 | $17.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-07 | $62.94K derived: sum of 2 quarters · filed 2019-08-07 | $53.14K 10-Q · filed 2019-08-07 | $87.17K derived: sum of 4 quarters · filed 2019-08-07 | |
| 2019-03-31 | $45.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | $35.99K 10-Q · filed 2019-05-09 | $70.02K derived: sum of 3 quarters · filed 2019-05-09 | $71.15K derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-12-31 | -$9.80K 10-Q · filed 2019-02-07 | $24.23K derived: sum of 2 quarters · filed 2019-02-07 | $25.36K derived: sum of 3 quarters · filed 2019-08-07 | $23.00K derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-09-30 | $34.03K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $35.16K derived: sum of 2 quarters · filed 2019-08-07 | $32.79K derived: sum of 3 quarters · filed 2019-08-07 | $30.42K 10-K · filed 2019-01-25 | |
| 2018-06-30 | $1.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-07 | -$1.23K derived: sum of 2 quarters · filed 2019-08-07 | -$3.60K 10-Q · filed 2019-08-07 | -$2.07K derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | -$2.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-09 | -$4.74K 10-Q · filed 2019-05-09 | -$3.21K derived: sum of 3 quarters · filed 2019-05-09 | -$40.46K derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$2.37K 10-Q · filed 2019-02-07 | -$839.00 derived: sum of 2 quarters · filed 2019-02-07 | -$38.09K derived: sum of 3 quarters · filed 2019-02-07 | -$26.59K derived: sum of 4 quarters · filed 2019-02-07 | |
| 2017-09-30 | $1.53K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | -$35.72K derived: sum of 2 quarters · filed 2019-01-25 | -$24.22K derived: sum of 3 quarters · filed 2019-01-25 | -$54.44K 10-K · filed 2019-01-25 | |
| 2017-06-30 | -$37.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | -$25.75K derived: sum of 2 quarters · filed 2018-08-09 | -$55.97K 10-Q · filed 2018-08-09 | -$24.57K derived: sum of 4 quarters · filed 2019-01-25 | |
| 2017-03-31 | $11.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | -$18.71K 10-Q · filed 2018-05-10 | $12.68K derived: sum of 3 quarters · filed 2019-01-25 | -$18.03K derived: sum of 4 quarters · filed 2019-01-25 | |
| 2016-12-31 | -$30.22K 10-Q · filed 2018-02-07 | $30.22K 10-Q · filed 2017-02-07 | $1.18K derived: sum of 2 quarters · filed 2019-01-25 | -$29.54K derived: sum of 3 quarters · filed 2019-01-25 | -$43.21K derived: sum of 4 quarters · filed 2019-01-25 |
| 2016-09-30 | $31.39K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $677.00 derived: sum of 2 quarters · filed 2019-01-25 | -$12.99K derived: sum of 3 quarters · filed 2019-01-25 | $2.51K 10-K · filed 2019-01-25 | |
| 2016-06-30 | -$30.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-07 | -$44.38K derived: sum of 2 quarters · filed 2017-08-07 | -$28.89K 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | -$13.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $1.83K 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $15.50K 10-Q · filed 2017-02-07 | ||||
| 2015-09-30 | $76.84K 10-K · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |